Market Research Industry Reports

Ocular Therapeutix, Inc. (OCUL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Ocular Therapeutix, Inc. (Ocular) formerly I-Therapeutix, Inc., is a biopharmaceutical company that develops therapies for diseases using hydrogel platform technology. The companys products include DEXTENZA, sustained release travoprost and posterior segment injections. Its hydrogel technology uses polyethylene glycol to create ophthalmic sustained drug delivery systems. Oculars hydrogel provides containment, localization and protection from inflammatory response, and a material for sustained delivery of drugs to the eye. The company also provides ReSure Sealant, a ocular sealant proven in clinical trial to be safe in sealing clear corneal incisions following cataract surgery. Its products are used for the treatment of glaucoma and ocular hypertension, post-operative inflammation, allergic conjunctivitis, dry eye and retinal diseases. Ocular is headquartered in Bedford, Massachusetts, the US.

Ocular Therapeutix, Inc. (OCUL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 3
List of Figures 4
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Ocular Therapeutix, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Ocular Therapeutix Raises US$8.5 Million In Series E Venture Financing 11
Ocular Therapeutix Raises US$24 Million In Extended Series D Financing 12
Ocular Therapeutix Secures US$14 Million In Series D Financing Round 14
Ocular Therapeutix Secures An Additional US$6 Million In Series C Round Of Financing 16
Equity Offering 18
Ocular Therapeutix Completes Exercise of Underwriters Over Allotment Option for IPO for USD75 Million 18
Ocular Therapeutix, Inc. - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ocular Therapeutix, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Ocular Therapeutix, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Ocular Therapeutix Raises US$8.5 Million In Series E Venture Financing 11
Ocular Therapeutix Raises US$24 Million In Extended Series D Financing 12
Ocular Therapeutix Secures US$14 Million In Series D Financing Round 14
Ocular Therapeutix Secures An Additional US$6 Million In Series C Round Of Financing 16
Ocular Therapeutix Completes Exercise of Underwriters Over Allotment Option for IPO for USD75 Million 18
Ocular Therapeutix, Inc., Key Competitors 20
Ocular Therapeutix, Inc., Key Employees 21
Ocular Therapeutix, Inc., Other Locations 22

List Of Figures


Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ocular Therapeutix, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Ocular Therapeutix, Inc., Medical Devices Deals, 2010 to YTD 2016 9

Global Ocular Cancer Drug Market Research Report 2018

Ocular Cancer Drug Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing on

USD 2850View Report

Ocular Therapeutix Inc (OCUL) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The companys products include DEXTENZA, sustained

USD 250View Report

Ocular Therapeutix, Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Ocular Therapeutix, Inc. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2016
No. of Pages :23
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube